Method for enhancing proliferation or differentiation of a...

Details Method for enhancing proliferation or differentiation of a... Method for enhancing proliferation or differentiation of a...

2006-07-11

2006-07-11

Landsman, Robert S. (Department: 1647)

Drug, bio-affecting and body treating compositions

Lymphokine

C530S351000, C424S085200, C514S012200

Reexamination Certificate

active

07074397

ABSTRACT:
Uses for WSX ligands in hematopoiesis are disclosed. In particular, in vitro and in vivo methods for stimulating hematopoiesis (e.g., myelopoiesis, erythropoiesis and especially, lymphopoiesis) using a WSX ligand (e.g., anti-WSX receptor agonist antibodies or OB protein), and optionally another cytokine, are described.

REFERENCES:
patent: 5116951 (1992-05-01), Druez et al.
patent: 5264416 (1993-11-01), Park et al.
patent: 5349053 (1994-09-01), Landolfi
patent: 5378808 (1995-01-01), D'Andrea et al.
patent: 5453491 (1995-09-01), Takatsu et al.
patent: 5455165 (1995-10-01), Capon et al.
patent: 5521283 (1996-05-01), DiMarchi et al.
patent: 5532336 (1996-07-01), DiMarchi et al.
patent: 5543320 (1996-08-01), Park et al.
patent: 5569744 (1996-10-01), Basinski et al.
patent: 5571513 (1996-11-01), Burstein
patent: 5580954 (1996-12-01), DiMarchi et al.
patent: 5599905 (1997-02-01), Mosley et al.
patent: 5605886 (1997-02-01), Basinski et al.
patent: 5635177 (1997-06-01), Bennett et al.
patent: 5635388 (1997-06-01), Bennett et al.
patent: 5639605 (1997-06-01), Kitamura et al.
patent: 5643748 (1997-07-01), Snodgrass et al.
patent: 5670373 (1997-09-01), Kishimoto et al.
patent: 5698389 (1997-12-01), de la Brousse et al.
patent: 5763211 (1998-06-01), Snodgrass et al.
patent: 5827734 (1998-10-01), Weigle et al.
patent: 5856098 (1999-01-01), Snodgrass et al.
patent: 5858967 (1999-01-01), Weigle et al.
patent: 5869610 (1999-02-01), Snodgrass et al.
patent: 5882860 (1999-03-01), Snodgrass et al.
patent: 5912123 (1999-06-01), Snodgrass et al.
patent: 5935810 (1999-08-01), Friedman et al.
patent: 5968779 (1999-10-01), Campfield et al.
patent: 5972621 (1999-10-01), Tartaglia et al.
patent: 6001968 (1999-12-01), Friedman et al.
patent: 6005080 (1999-12-01), Snodgrass et al.
patent: 6025325 (2000-02-01), Campfiled et al.
patent: 6124439 (2000-09-01), Friedman et al.
patent: 6355237 (2002-03-01), Snodgrass et al.
patent: 6506877 (2003-01-01), Tartaglia et al.
patent: 2002/0037553 (2002-03-01), Al-Barazanji et al.
patent: 2003/0203837 (2003-10-01), Pelleymounter
patent: 372752 (1990-06-01), None
patent: 0 396 387 (1990-11-01), None
patent: 0 396 387 (1990-11-01), None
patent: 0 741 187 (1996-11-01), None
patent: 0 956 862 (1999-11-01), None
patent: WO 91/01004 (1991-01-01), None
patent: WO 91/01743 (1991-02-01), None
patent: WO 94/05332 (1994-03-01), None
patent: WO 94/11404 (1994-05-01), None
patent: GB96/01388 (1995-06-01), None
patent: WO 95/14930 (1995-06-01), None
patent: WO 95/21864 (1995-08-01), None
patent: WO 96/03438 (1996-02-01), None
patent: WO 96/05309 (1996-02-01), None
patent: WO 96/08510 (1996-03-01), None
patent: WO 96/23517 (1996-08-01), None
patent: WO 96/24670 (1996-08-01), None
patent: WO 96/31526 (1996-10-01), None
patent: WO 96/34885 (1996-11-01), None
patent: WO 96/34885 (1996-11-01), None
patent: WO 96/35787 (1996-11-01), None
patent: WO 97/00319 (1997-01-01), None
patent: WO 97/12037 (1997-04-01), None
patent: WO 97/19952 (1997-06-01), None
patent: WO 97/25424 (1997-07-01), None
patent: WO 97/26272 (1997-07-01), None
patent: WO 97/26335 (1997-07-01), None
patent: WO 97/26370 (1997-07-01), None
patent: WO 97/26523 (1997-07-01), None
patent: WO 97/27286 (1997-07-01), None
patent: WO 97/41217 (1997-11-01), None
patent: WO 97/41263 (1997-11-01), None
patent: WO 97/48419 (1997-12-01), None
patent: WO 97/48806 (1997-12-01), None
patent: 98/18486 (1998-05-01), None
patent: WO 98/28427 (1998-07-01), None
Migliarcia et al., Blood 72(4) 1988, p. 1388.
Gainsford et al.PNAS93, 1996, p. 14564-68.
Cosman et al, TIBS 15, 1990, p. 265.
Schuld et al.,Cykinevol. 7, 1995, p. 679-80.
Shin et al.Inter. Rev. Immunol.10, 1993, p. 177-86.
Francis, Forms of Growth Factors, vol. 3, 1992 p. 4-10.
Koike et al.J Exp Med168, 1988, p. 879-90.
Ishigaka et alInt. Arch Allergy Appl Immunol1989, p. 46-49, vol. 84.
Bruno et al.Exp Dematol16, 1988, p. 371-77.
Arai et al., BioAssy 5(4) 1986, p. 166-71.
Gainsford et al.,PWAS93, 1996, p. 4564-68.
De Vas et al,JBC270(7) 1995 p. 15958.
Grunfill et al, Eur Cytokine Netw. vol. 7, 1996 p. 258.
Rousenoff et al., Arthritis & Pheumation, vol. 39(9) 1996, p. 577.
Ma et al, Surg Forum 1996, p. 47, p. 17-20.
Batra JK, et al. Mol. Immunol. 30(4):379-386, 1993.
Allen TM TiPS 15(7):215-220, 1994.
Zaghouni H, et al. Intern. Rev. Immunol. 10:265-278, 1993.
Ashkenazi et al., “Protection Against Endotoxic Shock by a Tumor Necrosis Factor Receptor Immunoadhesion”Proc. Natl. Acad. Sci.88:10535-10539 (1991).
Barinaga, M., “Obesity: Leptin Receptor Weighs In”Science271:29 (Jan. 5, 1996).
Bennet et al., “A role for Leptin and its cognate receptor in hematopoiesis”Current Biology6(9) :1170-1180 (Sep. 1, 1996).
Genbank, “Release 100”Homo sapiens cDNA clone 84708 5′(Mar. 2, 1995).
Antibodies. A Laboratory Manual, Harlow and Lane, Cold Spring Harbor Laboratory pp. 341 (1988).
“Polyethylene glycol and derivatives”Catalog Shearwater Polymers, Inc., Functionalized Biocompatible Polymers for Research(Jan. 1994).
Ashkenazi and Chamow, “Immunoadhesins: An Alternative to Human Monoclonal Antibodies”Methods: A Companion to Methods in Enzymology8:104-115 (1995).
Barin, Marcia, ““Obese” protein slims mice”Science269:475-476 (1995).
Baumann et al., “Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells”Molecular&Cellular Biology14(1) :138-146 (1994).
Beck et al., “Generation of soluble interleukin-1 receptor from an immunoadhesin by specific cleavage”Molecular Immunology31(17):1335-1344 (1994).
Bennett et al., “Extracellular Domain-IgG Fusion Proteins for Three Human Natriuretic Peptide Receptors. Hormone Pharmacology and Application to Solid Phase Screening of Synthetic Peptide Antisera”The Journal of Biological Chemistry266(34):23060-23067 (Dec. 5, 1991).
Campfield et al., “Recombinant mouse ob protein: evidence for peripheral signal linking adiposity and central neural networks”Science269:546-549 (1995).
Carter et al.Mutagenesis. A Practical Approach, Mcpherson,ed., Oxford, UK:IRL Press vol. Chapter 1:1-25 (1991).
Carter et al., “Engineering Subtilisin BPN' for Site-Specific Proteolysis”Proteins: Struct. Funct. . Genet.6:240-248 (1989).
Carter et al., “Humanization of an anti-pl185HER2antibody for human cancer therapy”Proc. Natl. Acad. Sci.89:4285-4289 (1992).
Chen et al., “Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice”Cell84:491-495 (1996).
Cioffi et al., “Novel B219/OB receptor isoforms: possible role leptin in hematopoiesis and reproduction”Nature2(5) :585-589 (1996).
Colditz, G.A., “Economic costs of obesity”Am. J. Clin. Nutr.55:503S-507S (1992).
Coleman and Hummal, “Effects of parabiosis of normal with genetically diabetic mice”Am. J. Physiol.217:1299-1304 (1969).
Coleman et al., “Obese and Diabetes: Two Mutant Genes Causing Diabetes-Obesity Syndromes in Mice”Diebetologia14:141-148 (1978).
Coleman, D. L., “Effects of parabiosis of obese with diabetes and normal mice”Diabetol9:294-298 (1973).
Considine, R. et al., “Serum immunoreactive-leptin concentrations in normal-weight and obese humans”The New England Journal of Medicinepp. 292-295 (Feb. 1, 1996).
D'Andrea, A. D., “Cytokine receptors in congenital hematopoietic disease”New England J. of Medicine330(12) :839-846 (1994).
Dexter et al., “Growth and Differentiation in the Hemopoietic System”Ann. Rev. Cell Biol.3:423-441 (1987).
Eisenberg, R., “Structure and Function in Gene Patenting”Nature Genetics15:125-129 (1997).
Friedman et al., “Molecular mapping of the mouse ob mutation”Genomics11:1054-1062 (1991).
Fukunaga R. et al., “Functional domains of the granulocyte colony-stimulating fa

Affiliated with

Also associated with

Rating

Method for enhancing proliferation or differentiation of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for enhancing proliferation or differentiation of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for enhancing proliferation or differentiation of a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3590271